Functional decline associated with polypharmacy and potentially inappropriate medications in community-dwelling older adults with dementia
- PMID: 22207646
- PMCID: PMC3298080
- DOI: 10.1177/1533317511432734
Functional decline associated with polypharmacy and potentially inappropriate medications in community-dwelling older adults with dementia
Abstract
This study provides empirical evidence on whether polypharmacy and potentially inappropriate prescription medications (PIRx, as defined by the 2003 Beers criteria) increase the likelihood of functional decline among community-dwelling older adults with dementia. Data were from the National Alzheimer's Coordinating Center, Uniform Data Set (9/2005-9/2009). Study sample included 1994 community-dwelling participants aged ≥65 with dementia at baseline. Results showed that participants having ≥5 medications were more likely to have functional decline than participants having <5 medications. However, the increased likelihood was only apparent in participants who did not have PIRx. Instead of magnifying the associated risk as hypothesized, PIRx appeared to have a protective effect albeit marginally statistically significant. Therefore, increased medication burden may be associated with functional decline in community-dwelling older adults with dementia who are not prescribed with PIRx. More research is needed to understand which classes of medications have the most deleterious effect on this population.
Conflict of interest statement
The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
References
-
- Healthy People 2020: Understanding and Improving Health. Office of Disease Prevention and Health Promotion, U.S. Department of Health and Human Services. 2020. http://www.healthypeople.gov/2020/topicsobjectives2020/overview.aspx? topicid=27. Accessed June 24, 2011.
-
- Bynum JP, Rabins PV, Weller W, Niefeld M, Anderson GF, Wu AW. The relationship between a dementia diagnosis, chronic illness, medicare expenditures, and hospital use. J Am Geriatr Soc. 2004; 52(2): 187–194. - PubMed
-
- Carnahan RM, Lund BC, Perry PJ, Chrischilles EA. The concurrent use of anticholinergics and cholinesterase inhibitors: rare event or common practice? J Am Geriatr Soc. 2004; 52(12): 2082–2087. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical